inveox
Garching Bei M├╝nchen
About inveox
inveox is a Munich-based company with the goal of making cancer diagnoses faster, safer, and more reliable. In today’s labs, tissue samples (biopsies) are subject to anywhere between 1-15% chance of mix-ups, contamination or loss. But our products are designed to work as a cohesive unit to make this a thing of the past and create the lab of the future. In addition, we bring big data, AI and machine learning to labs in order to provide better research data for scientists so they can eradicate cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $19.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2019)
- Website: inveox.com
- Phone: +49 (0) 89 / 57 84 76 01
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/inveox-173271 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.